This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignees: Tongji University, Shanghai East Hospital. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Subas Man Sakya: Innovator in Ion Channel Antagonists
Introduction
Subas Man Sakya is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of ion channel antagonists and blockers. His work is crucial for advancing treatments for heart disease and other related conditions.
Latest Patents
Subas Man Sakya holds a patent for "Ion channel antagonists/blockers and uses thereof." This patent provides compounds of formula (I) or pharmaceutically acceptable salts, stereoisomers, solvates, or prodrugs. The preparation method and applications of these compounds are detailed in the patent specification. The pharmaceutical composition developed is particularly useful for treating heart disease and other ion channel-related diseases. He has 1 patent to his name.
Career Highlights
Subas Man Sakya is affiliated with Shanghai East Hospital, where he applies his expertise in pharmaceutical research. His work focuses on innovative solutions that address critical health issues, particularly those related to ion channels.
Collaborations
He collaborates with talented coworkers, including Yihan Chen and Dandan Liang, to further enhance the impact of his research and innovations.
Conclusion
Subas Man Sakya's contributions to the field of ion channel antagonists represent a significant advancement in pharmaceutical science. His work not only showcases his innovative spirit but also holds promise for improving treatments for various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile